Search results
Results from the WOW.Com Content Network
Pages in category "League of Legends mid lane players" The following 29 pages are in this category, out of 29 total. This list may not reflect recent changes. B.
Dyrus was the top laner for Team SoloMid (TSM) for most of his professional League of Legends career. With TSM, he won several LCS titles and appeared at several World Championships . He retired from professional play after the 2015 World Championship , although he briefly returned to play in 2017.
TSM's fortunes fluctuated in the subsequent years, but in 2013, they became the inaugural North American League of Legends Championship Series (NA LCS) champions. They maintained their status as a top team in North America, with appearances in multiple World Championships. In late 2013, TSM signed Danish mid laner Søren "Bjergsen" Bjerg. [59]
William Li (born November 25, 1989), better known as Scarra, is an American Twitch streamer and former professional League of Legends player. [2] [3] He is most well known for being the mid laner for Team Dignitas. [3] [4] Li is a co-founder of OfflineTV, an online social entertainment group of content creators.
Andy Dinh (born April 19, 1992), better known as Reginald, is an American entrepreneur and former professional League of Legends player. He is the founder, owner, and CEO of Team SoloMid (TSM), an esports organization most well known for its League of Legends team in the League Championship Series (LCS).
The Mid-Season Invitational (MSI) is an annual League of Legends international tournament hosted by Riot Games in the middle of years, since 2015. It is the second most important international League of Legends tournament aside from the World Championship.
An integrating ADC is a type of analog-to-digital converter that converts an unknown input voltage into a digital representation through the use of an integrator.In its basic implementation, the dual-slope converter, the unknown input voltage is applied to the input of the integrator and allowed to ramp for a fixed time period (the run-up period).
Schematic structure of an antibody–drug conjugate (ADC) Antibody–drug conjugates or ADCs are a class of biopharmaceutical drugs designed as a targeted therapy for treating cancer. [1] Unlike chemotherapy, ADCs are intended to target and kill tumor cells while sparing healthy cells. As of 2019, some 56 pharmaceutical companies were ...